BioNTech SE (BNTX) Other Accumulated Expenses (2018 - 2023)

BioNTech SE (BNTX) has 6 years of Other Accumulated Expenses data on file, last reported at $52.6 million in Q3 2023.

• In Q3 2023, Other Accumulated Expenses fell 36.33% year-over-year to $52.6 million; the TTM figure through Sep 2023 stood at $52.6 million (down 36.33% YoY), while the FY2020 annual figure was $1.1 million, up 27.22% from the prior year.
• Other Accumulated Expenses retreated to $52.6 million in Q3 2023, from $82.6 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $82.6 million in Q3 2022 and bottomed at $843448.4 in Q4 2019.
• A 5-year average of $23.5 million and a median of $12.9 million in 2021 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2019 — Other Accumulated Expenses plunged 87.95% — and 2022, when it surged 542.42%.
• Year by year, Other Accumulated Expenses stood at $843448.4 in 2019, then gained by 27.22% to $1.1 million in 2020, then surged by 1097.9% to $12.9 million in 2021, then surged by 542.42% to $82.6 million in 2022, then plunged by 36.33% to $52.6 million in 2023.
• The last three Other Accumulated Expenses figures came in at $52.6 million (Q3 2023), $82.6 million (Q3 2022), and $12.9 million (Q3 2021), per Business Quant data.

Peer Comparison